Clinical trial
Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation
NCT04234932 is registered in ClinicalTrials.gov with University of the Incarnate Word as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation
- Lead sponsor
- University of the Incarnate Word
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- January 6, 2020
- Completion date
- January 31, 2021
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.